ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Caladrius Biosciences Inc

Caladrius Biosciences Inc (CLBS)

0.4264
0.00
(0.00%)
Closed September 18 4:00PM
0.4264
0.00
( 0.00% )
Pre Market: 8:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.4264
Bid
0.4264
Ask
0.43
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
0.4264
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
8,150,000
Dividend Yield
-
PE Ratio
-1.15
Earnings Per Share (EPS)
-2.56
Revenue
-
Net Profit
-20.84M

About Caladrius Biosciences Inc

Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The company is developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the... Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The company is developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. Its current product candidates include XOWNA, HONEDRA and CLBS201. Show more

Sector
Health & Allied Services,nec
Industry
Insurance Carriers, Nec
Headquarters
Wilmington, Delaware, USA
Founded
2006

CLBS Latest News

Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics

Company to commence trading on The Nasdaq Capital Market under Ticker Symbol “LSTA” Lisata has approximately $76 million in cash and investments following transaction close Lisata strengthens...

Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata Therapeutics

BASKING RIDGE, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), announced today that, based upon the final vote count certified...

Life Sciences Virtual Investor Conference Agenda Announced for September 15th

NEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Life Sciences Virtual...

Caladrius Biosciences Announces Participation in Upcoming Investor Conferences in September 2022

BASKING RIDGE, N.J., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company developing...

Caladrius Biosciences’ Prospective Merger Partner, Cend Therapeutics, Announces Collaboration Agreement with Roche to Evaluate CEND-1 in Combination with Immunotherapy to Treat Pancreatic Cancer

Study to be part of Roche’s Morpheus Platform designed to enable more rapid and efficient development of novel cancer immunotherapy combinations Agreement accelerated by Caladrius’ initial...

Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update

Merger with Cend Therapeutics remains on track to close in the third quarter of 2022, subject to stockholder approval, resulting in the formation of Lisata Therapeutics Conference call begins...

Caladrius Biosciences Completes Enrollment in Phase 1b Study of CLBS201 for the Treatment of Diabetic Kidney Disease

BASKING RIDGE, N.J., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company developing innovative...

Caladrius Biosciences to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time

BASKING RIDGE, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company developing innovative...

Caladrius Biosciences and Cend Therapeutics Announce Publication of Pancreatic Cancer Trial Data in The Lancet Gastroenterology and Hepatology

BASKING RIDGE, N.J. and SAN DIEGO, July 06, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TBIOTelesis Bio Inc
$ 3.90
(186.76%)
11.15M
XCURExicure Inc
$ 6.00
(162.01%)
4.15M
ZEOZeo Energy Corporation
$ 2.79
(144.74%)
4.93M
VEROVenus Concept Inc
$ 0.8461
(68.38%)
4.83M
GLMDGalmed Pharmaceuticals Ltd
$ 10.23
(48.26%)
3.68M
PGNYProgyny Inc
$ 18.52
(-24.22%)
109.32k
VVOSVivos Therapeutics Inc
$ 3.28
(-20.58%)
437.67k
ATMCAlphaTime Acquisition Corporation
$ 9.00
(-19.64%)
10
HPAIHelport AI Ltd
$ 4.78
(-18.98%)
64
HAOHaoxi Health Technology Ltd
$ 2.44
(-18.67%)
19.09k
FRGTFreight Technologies Inc
$ 0.162
(30.75%)
30.76M
MAXNMaxeon Solar Technologies Ltd
$ 0.10
(10.01%)
16.28M
TBIOTelesis Bio Inc
$ 3.90
(186.76%)
11.15M
SQQQProShares UltraPro Short QQQ
$ 7.88
(-6.19%)
5.87M
VMARVision Marine Technologies Inc
$ 0.7282
(20.76%)
5.76M

Discussion

View Full Feed
glenn1919 glenn1919 1 minute ago
vero...............comm......................................https://www.stockscores.com/charts/charts/?ticker=VERP
https://www.stockscores.com/charts/charts/?ticker=COMM
neomania neomania 2 minutes ago
how would you know what news is coming. You have inside information. This is the stuff they are sorting out in the courts.
NSAV
jedijazz jedijazz 2 minutes ago
$CBDW Green close as expected. Love the way this is trading. @CBDWInc www.cbdw.ai #AI #Biotech #Adnexus
CBDW
uksausage uksausage 2 minutes ago
big financing news, an immediate $40M+ cash from sale/leasing deal on their hydrogen liquefaction/storage equipment.
FCEL
Thomas@yahoo Thomas@yahoo 2 minutes ago
https://hemptoday.net/early-study-shows-epidiolex-may-have-potential-as-treatment-for-illness-in-veterans/
CVSI
TrendTrade2016 TrendTrade2016 2 minutes ago
THE PUMPING CLOWNS THAT ARE PREACHING TO OTHER CLOWNS ABOUT A BILLION SHARE REDUCTION IS AN OLE OTC SCAM...WE SEE IT TIME AND TIME AGAIN....
ICTY
jedijazz jedijazz 2 minutes ago
$CBDW Green close as expected. Love the way this is trading. @CBDWInc www.cbdw.ai #AI #Biotech #Adnexus $NVDA $AVGO
AVGO CBDW NVDA
Dantheoneman Dantheoneman 3 minutes ago
Dude! Did you read News? They are Getting into Significant Revenue Scale without dropping $1 into Deal. This is Multi-Runner. Dollar Status most likely
SGN
Penny chatter Penny chatter 3 minutes ago
Go-ahead and short it
OMEX
Tree Tree 3 minutes ago
Good morning my little wild cards!
Money hunt Money hunt 3 minutes ago
And then to the moon dude!! Spacesuit ready!!!
FOXO
Huggy Bear Huggy Bear 4 minutes ago
Don't forget the CONsultants...
IFUS
TrendTrade2016 TrendTrade2016 4 minutes ago
ON THE WEEKLY...MAJOR CONTRADICTION ON LEADING INDICATORS AS THE PUMPING CLOWNS GET THE TENT UP WITH VERY LITTLE SUPPORT...
ICTY
koldkash koldkash 5 minutes ago
SGN has that 1$ feel
SGN
Pnypnchr Pnypnchr 5 minutes ago
Yep that's all this site is good for, drama lies and hopeium.
AAPJ
Investor082 Investor082 6 minutes ago
Nope, not if the approval comes with conditions and no significant backing from big pharma or institutional investor. There is no hiring. So market will not believe LP is serious about commercialization. We could see a less than 50% spike and sell off in the next day or two if there is no major foll
NWBO
TrendTrade2016 TrendTrade2016 6 minutes ago
LETS BRING SOME LIGHT TO THE CLOWN DANCE...FAKE AQUISITION SCAM HERE INTO THE RINSE!!!!
ICTY
Emmatf Emmatf 6 minutes ago
Try BLR https://www.blrtools.com/data-recovery-wizard.html Data Recovery Tool

BLR Data Recovery Tool is a professional data recovery solution for PC and any Windows-compatible devices. Whether users want to recover lost data from Windows desktop, laptop, or compatible devices such
USB
tradernewstip tradernewstip 6 minutes ago
$LPTH News! LightPath Launches Next Gen Mantis(TM) Camera into $500 Million Global Furnace Monitoring Market
https://finance.yahoo.com/news/lightpath-launches-next-gen-mantis-123000011.html
LPTH
timberwolf7 timberwolf7 7 minutes ago
oyster: so THIS doesn't count as 'rape'??

"I remember her saying, here was this person that she was working for and she idolized him," LaCasse said. "And he kind of put her up against a wall. And put his hand up her skirt and he put his fingers inside her. She felt like she was ass
glenn1919 glenn1919 9 minutes ago
tbio................................https://stockcharts.com/h-sc/ui?s=TBIO&p=W&b=5&g=0&id=p86431144783
TBIO
Newc Newc 9 minutes ago
Nice. $pbm news
OHM
timberwolf7 timberwolf7 10 minutes ago
satter: ashley bidens diary confirmed to be REAL..

PS: you have any PROOF of your claims about TRUMP??

PS: no one but braindead commies like yourself believe whats her name
there in new york. Why as soon as the rigged trial was over, the commies
me

Your Recent History

Delayed Upgrade Clock